PREPARATION OF CALCIUM PHOSPHATE BIOCERAMIC POWDERS SYNTHESIZED IN SIMULATED BODY FLUID MEDIA by -, Bambang Sunendar & -, Weko Abhinimpuno
 
 
 
Preparation of Calcium Phosphate Bioceramic Powders Synthesized in Simulated Body Fluid 
Media (Bambang Sunendar and Weko Abhinimpuno) 
 
 1 
PREPARATION OF CALCIUM PHOSPHATE BIOCERAMIC POWDERS 
SYNTHESIZED IN SIMULATED BODY FLUID MEDIA 
 
Bambang Sunendar and Weko Abhinimpuno 
Material Processing Laboratory, Engineering Physics Study Program 
Institute of Technology Bandung, Lab. Tek VI, 1st floor. 
Jl. Ganesha No 10, Bandung – 40132 
Tlp. 62-22-2534174, e-mail : purwa@tf.itb.ac.id 
 
 
ABSTRACT 
 
In this study, calcium phosphate bioceramics powders were synthesized using 
Ca(NO3)2.4H2O and (NH4)2HPO4 as the precursor  by a biomimetic process. The 
condition of the synthesizing process is set mimicking the human physiological 
environment. The synthesized samples then were dried and calcined at several 
temperatures. The samples were studied after characterized by XRD, FT-IR, EDS 
and SEM. The process in this study was successful in synthesizing various types of 
calcium phosphate bioceramics.  
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PREPARASI POWDER BIOKERAMIK KALSIUM PHOSPHATE  
DISINTESA DI DALAM MEDIA SIMULATED BODY FLUID  
 
ABSTRAK 
 
Pada Penelitian ini powder biokeramik kalsium phospate disintesa mengunakan 
Ca(NO3)2.4H2O dan (NH4)2HPO4  sebagai prekursor dengan methoda biomimetic 
process. Situasi proses sintesa di buat meniru lingkungan physiologi manusia. 
Sampel-sampel hasil sintesa kemudian dikeringkan dan dikalsinasi pada beberapa 
temperatur. Sampel-sampel hasil sintesa tadi dikarakterisasi mengunakan XRD, FT-
IR, EDS dan SEM. Proses yang digunakan dalam penelitian ini telah berhasil 
disintesa beberapa jenis biokeramik kalsium phosphate. 
 
Kata kunci : Biokeramik, kalsium phospate, proses biomimetik 
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INTRODUCTION 
 
The need of better and faster healing method for patients has increased the 
demand of biomaterial in the biomedical field. One type of the biomaterial that 
interested scientist and clinician to be studied and developed is a synthetic 
“Calcium Phosphate” based bioceramics. As we know, calcium and phosphate are 
the main elements of the human hard tissue mineral. 
The most widely used calcium phosphate based bioceramics are 
hydroxyapatite (HA, Ca10(PO4)6(OH)2), β-tricalcium phosphate (β-TCP, Ca3(PO4)2) 
and biphasic mixtures of these two. At present, synthetic calcium phosphate 
bioceramics are widely used in the area of orthopedic, dentistry and drug delivery. 
Further researches showed that calcium phosphate bioceramics are possible to be 
use as an ocular implant (B. Kundu et al. 2004) and also genetic therapy for 
certain types of tumors/cancers (Zhi-Su Liu et al. 2003) .  
Considering the numerous applications of calcium phosphate bioceramics in 
biomedical fields, various synthesis techniques have been developed. Calcium 
phosphate bioceramics have been synthesized using several methods including the 
wet chemical precipitation , sol-gel, solid state reaction and hydrothermal method. 
Their presences are in the form of powders, granules, foams, dense and porous 
blocks, coating, cement, and also various composites. 
Another possible technique to synthesize calcium phosphate bioceramics is by 
biomimetic (bio=life, mimetic=mimicking) method. In this method, calcium 
phosphate based bioceramics are precipitated in mimicking the condition of the 
physiological environment of the human body. The media used for the precipitation 
simulates body fluid (SBF), an inorganic solution with ion concentrations and a pH 
value similar to human blood plasma. Some studies of this method reported that 
this technique has been successful in synthesizing calcium phosphate bioceramics 
powders which are similar with those in the human bone (T.V. Thamaraiselvi et al. 
2006; A. Cüneyt Tas. 2000; Defne Bayraktar and A. Cüneyt Tas. 2000). 
 
 
 
 
Preparation of Calcium Phosphate Bioceramic Powders Synthesized in Simulated Body Fluid 
Media (Bambang Sunendar and Weko Abhinimpuno) 
 
 3 
METHODES AND MATERIALS 
 
Processes of study and experiment conducted are given in the flowchart of the 
Figure1. 
 
 
Calcium Source
0.15 M Ca(NO3)2.4H2O
(pH 7.4, pH 9.5)
Phosphate Source
0.15 M (NH4)2HPO4 
(pH 7.4, pH 9.5)
Mix & Stirr
T=37
o
C, 24 hours
Filter Washed
Calcination
- 700
o
C, 6 hours
- 900
o
C, 6 hours
- 1100
o
C, 6 hours
Characterization
- SEM & EDS
- FT-IR
-XRD
Discussion & 
Conclusion
Start Literature Reveiw
Finish
Drying
105
o
C, 6 hours
SBF Soultion
(Hanks Balanced Salt Solution)
 
 
Figure 1 Process flowchart of the study 
 
Simulated Body Fluid (SBF) used in this study was Hanks Balanced Salt Solution 
(HBSS). Pro-analyst grade of NaCl, CaCl2, KCl, MgCl2.6H2O, MgSO4.7H2O, NaHCO3, 
Na2H2PO4, and Na2HPO4.2H2O were used in the preparation of SBF. Reagent were 
dissolved one by one in de-ionized water at appropriate quantities based on the 
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appendix of ASTM F 2129-04. The comparison of ion concentration between HBSS 
and human blood plasma can be seen in Table 1. 
 
Table 1. Ion concentrations of human blood plasma and SBF (mM) 
 
Ion Blood Plasma HBSS 
Na+ 
K+ 
Mg+ 
Ca2+ 
Cl- 
HCO3
- 
HPO4
2- 
SO4
2- 
130-155 
4.0-5.6 
1.6-2.2 
4.0-5.5 
100-110 
24-30 
1.6-2.7 
0.7-1.5 
141.7 
5.7 
0.8 
1.7 
145.6 
4.2 
0.7 
0.8 
 
A series of experiment were performed over two different pH range. Pro-
analyst grade of calcium nitrate tetrahydrate salt (Ca(NO3)2.4H2O) were used in the 
precipitation as the calcium ion sources. Phosphate ion sources are obtain from 
pro-analyst grade of di-ammonium hydrogen phosphate salts ((NH4)2HPO4). Each 
precursor was dissolved separately in SBF, depending on the set of experiment. 
The concentration of Ca(NO3)2.4H2O and (NH4)2HPO4 were set as 0.15 M.  
After the precursors were ready, each solution of precursor was adjusted at 
acidity of pH level 7.4 and 9.5 by adding some amount of 6 M NH4OH solution. 
Then amount volume of 0.15 M Ca(NO3)2.4H2O and 0.15 M (NH4)2HPO4 solution 
were added together with the molar ratio of Ca/P about 1.67. The solution then 
were stirred for 24 hours with reaction temperature maintained at 37oC. 
The resulting products were filtered, washed and dried in air oven at 105oC. 
Then the products were calcined for 6 hours. The calcination temperatures were 
conducted at 700oC, 900oC and 1100oC. 
In this study the samples were characterized by Fourier-transform infrared 
spectroscopy (FT-IR), X-ray diffraction (XRD), Scanning electron microscopy (SEM) 
and Energy dispersive X-ray spectroscopy (EDS). X-Powder software was used to 
help processing the XRD data. 
 
RESULTS AND DISCUSSION 
 
During the process, the acidity in the reaction increased. In the first sample, 
the precipitations occured mostly in the acid region. In the second sample, all of 
the precipitations occurred in the alkaline (base) region.  
The EDS semi-quantitative analysis was conducted to calculate the approximate 
Ca/P mol ratio. This will help to identify and verify the compound result. The 
approximate Ca/P molar ratio for each sample was belowed the stoichiometric Ca/P 
of β-TCP (1.5) and HA (1.67). Only sample II with calcination was at 1100oC. 
 
 
 
Preparation of Calcium Phosphate Bioceramic Powders Synthesized in Simulated Body Fluid 
Media (Bambang Sunendar and Weko Abhinimpuno) 
 
 5 
The change of pH values and semi-quantitative EDS results for Ca/P molar ratios 
are presented in Table 2. 
 
Table 2. Change of pH value and Ca/P molar ratio 
 
No 
pH 
Calcination 
Ca/P 
mol Initial Final 
I 7.4 4.8 700oC 1.00 
II 9.5 7.7 
700oC 1.39 
1100oC 1.47 
 
XRD and FT-IR analyses were conducted to identify the phase of compound 
synthesized. The main phase identified from the XRD analyses for each sample is 
given in Figure 2. 
 
 
Figure 2 Peak search for the main phase 
 
FT-IR analyses are needed to verify the XRD analyses. The spectra of FT-IR for 
each sample at various calcinations are presented at Figure 3 and Figure 4. 
 
 
 
 
 
Jurnal Bionatura, Vol. 11, No. 1, Maret 2009 :  -  
 
 6 
 
 
Figure 3 FT-IR spectra of sample I 
 
 
Figure 4. FT-IR spectra of sample II 
 
All of the FT-IR spectra from the dried sample showed content of carbonate 
(CO3
-) ions from the wavenumber of ± 2368 cm-1, ± 1460 cm-1, and ± 875 cm-1. 
The carbonate ions probably occured from the impurities. Beside carbonate, 
possible bondings found in the spectra are from NH4
- and NO3
-. Another possibility 
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is the presence of hydroxyl (OH-) ion from the moist of sample. Upon calcination, 
those bonding are slightly disappeared; this occurred due to the evaporation of the 
ions. 
The main phase of the sample after calcinations at 700oC is Calcium 
Pyrophosphate (CPP, Ca2P2O7). This is identified by matching the main peaks of 
XRD (Figure 2) and analyzing the fingerprint of FT-IR spectra (Figure 3). The XRD 
main peaks are matched with the PDF card number 09-0346 from JCPDS. The 
fingerprint of FT-IR from the range of 500 cm-1 - 1250cm-1 are matched with the 
fingerprint of pyrophosphate (P2O7
4-) studied by Tas and Badhuri (A Cuneyt Tas 
and Sarit B Bhaduri. 2004) and Parekh and Joshi (Bharat B. Parekh and Mihir J. 
Joshi. 2007). 
The main phase synthesized in sample I confirms the study done Tas and 
Badhuri (A Cuneyt Tas and Sarit B Bhaduri. 2004). In their study, CPP was 
synthesized by the condensation of Calcium Hydrogen Phosphate salts (CHP, 
CaHPO4). The CHP can be prepared using soluble calcium (e.g., Ca(NO3)2.4.H2O, 
CaCl2.2H2O or Ca(CH3COO)2.H2O) and phosphate (e.g., (NH4)2HPO4, NH4H2PO4, 
Na2HPO4, NaH2PO4, KH2PO4 or K2HPO4) as long as the solution pH is kept in the 
acid range. This confirms that the FT-IR spectra fingerprint of the dried sample I 
from the range of 500 cm-1 - 1250cm-1 are similar with CHP salts studied by Tas 
and Badhuri (A Cuneyt Tas and Sarit B Bhaduri. 2004). When heating upon 700oC, 
CHP thermally decompose by a condensation reaction.  
In sample II, the main phase of the sample after calcinations at 700oC were 
HA and Rhenanite (NaCaPO4). Upon calcination at 1100
oC, the main phase of of 
sample II change into β-TCP. This is identified by matching the main peaks of XRD 
(Figure 2) and the fingerprint of FT-IR spectra (Figure 4). The XRD main peaks are 
matched with the PDF card number 25-0166 for HA, 29-1193 for Rhenanite and 
09-0169 for β-TCP. The fingerprint of FT-IR are matched with the studied by Tas 
(A Cuneyt Tas. 2000), Bayraktar and Tas (Defne Bayraktar and A. Cüneyt Tas. 
2000), Markovic et. al. (Milenko Markovic et al, 2004), and Jalota et. al. (Sahil 
Jalota et al. 2006). The spectra of orthophosphate detected in the FT-IR is 
represent from the main phase (HA, Rhenite and β-TCP), which those three phases 
have orthophosphate ion in their compound. The hydroxyl ion detected in the 
range of 3400 cm-1 – 3600 cm-1 of the FT-IR spectra confirms the presence of HA 
compound. The decreasing spectra of hydroxyl ion at higher calcination 
temperature in the range of 3400 cm-1 – 3600 cm-1 of the FT-IR spectra confirms 
the thermal decomposition of HA into β-TCP. 
The main phase synthesized in sample II calcined at 700oC shows different 
results with the biomimetic process done by Tas (A Cuneyt Tas. 2000) and 
Thamaraselvi et. al. (T.V. Thamaraiselvi et al. 2006). Although the reaction done 
by Tas (A Cuneyt Tas. 2000), Thamaraselvi et. al. (T.V. Thamaraiselvi et al. 2006), 
and the author occured in the base region but the results are different. In their 
studies, the powder synthesized by the biomimetic process result in HA powders 
with approximate purity over 90%. In this study, the powder synthesized results in 
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a biphasic mixture of HA and Rhenanite. This phenomena happened occured the 
different adjustment of pH level. Tas (A Cuneyt Tas. 2000) and Thamaraselvi et. 
al. (Thamaraiselvi et al. 2006) adjusted the acidity at a constant level of pH 7.4 by 
the continuous addition of NH4OH. While the author used initial addition of NH4OH, 
set up at pH level of 9.5 and finished at the level of 7.7. It seems that different 
kinds of pH treatment could significantly change the result. 
The biphasic result of the second sample calcined at 700oC is quite similar with 
the study of Jalota et. al. (Sahil Jalota et al. 2006). In their study, the synthesized 
powders calcined at 300oC to 600oC resulted in a biphasic mixture of approximate 
composition of 60% HA and 40% Rhenanite using different precursor 
(Ca(NO3)2.4H2O, Na2HPO4 and NaHCO3). They proposed their biphasic mixture as a 
new (potential) biomaterial for skeletal repair. While in this study, the main 
biphasic mixture of the sample calcined at 700oC are approximately 41% HA and 
34.3% Rhenanite. If this sample is studied at lower calcinations temperature, there 
is a great possibility that this sample could result in similar composition with the 
one studied by Jalota et. al. (Sahil Jalota et al. 2006).  
The result of material characterization from XRD, EDS and FT-IR verifies the 
phase and compound identification, especially for the main phases and compound. 
The FT-IR fingerprint spectra show similarity of the main compound presence with 
the result of XRD analysis. The XRD analysis and the EDS analysis show similar 
trend of Ca/P molar ratio (Figure 5).  
 
 
 
 
Figure 5. Comparison Ca/P ratios in the study 
 
The SEM images of the samples (Figure 6), show that the particle synthesized 
are in the range of sub-micron to micron. Sample I result in a flake-like particles 
while sample II results in spherical particles.  
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Figure 6.  SEM images of (a) sample I calcined at 700oC; (b) sample II calcined 
at 700oC and (c) sample II calcined at 1100oC 
 
The summary of the main phase synthesized in this study is given in Table 3. 
 
Table 3. Summary of the main phase 
 
No Calcination Main Phase 
I 700oC CPP 
II 
700oC HA & Rhenanite 
1100oC β -TCP 
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The authors realize that the human mimicking condition in the experiments of 
this study is still far away from the real human condition. It is amazing to see how 
nature could work efficiently in a very complicated mechanism. Developing the 
biomimetic method with reproducing all the sequence of biomineralization steps 
and condition will lead to unbearable cost.  
The biomimetic process has been applied also for coating of medical implant. 
Based on ASTM 2024-00, the requirement for the coating must have a minimum 
HA content of 50%. While in this study, the HA content of biomimetic process 
(sample II calcined at 700oC) results in 41%. For applying in biomimetic coating, 
the authors recommends some modification of the process. Those are by adjusting 
the acidity of the process at certain constant level of pH at the base range and also 
increasing the concentration of precursor. 
 
CONCLUSION 
 
Calcium phosphate bioceramics has been successfully synthesized in this study. 
The body mimicking condition of synthesized process did not result in calcium 
phosphate bioceramics that have significant similarity with the one produced in the 
real body system. Finding of biphasic mixture of HA and rhenanite (NaCaPO4), 
similar to research done by Jalota et. al., (Sahil Jalota et al. 2005); while main 
phases, Ca/P trend confirmation by means of XRD and FTIR shape. 
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